Fate Therapeutics, Inc. (FATE)
2.435
+0.10
(+4.51%)
USD |
NASDAQ |
Aug 24, 16:00
2.435
0.00 (0.00%)
After-Hours: 20:00
Fate Therapeutics Market Cap : 284.15M for Aug. 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 21, 2026 | 271.90M |
| August 20, 2026 | 285.90M |
| August 19, 2026 | 309.24M |
| August 18, 2026 | 298.74M |
| August 17, 2026 | 305.74M |
| August 14, 2026 | 299.90M |
| August 13, 2026 | 294.07M |
| August 12, 2026 | 317.41M |
| August 11, 2026 | 319.74M |
| August 10, 2026 | 322.08M |
| August 07, 2026 | 325.56M |
| August 06, 2026 | 289.52M |
| August 05, 2026 | 302.31M |
| August 04, 2026 | 298.82M |
| August 03, 2026 | 290.68M |
| July 31, 2026 | 284.87M |
| July 30, 2026 | 291.84M |
| July 29, 2026 | 274.40M |
| July 28, 2026 | 269.75M |
| July 27, 2026 | 282.54M |
| July 24, 2026 | 280.22M |
| July 23, 2026 | 293.01M |
| July 22, 2026 | 299.98M |
| July 21, 2026 | 329.05M |
| July 20, 2026 | 324.98M |
| Date | Value |
|---|---|
| July 17, 2026 | 323.24M |
| July 16, 2026 | 317.42M |
| July 15, 2026 | 347.65M |
| July 14, 2026 | 347.65M |
| July 13, 2026 | 351.14M |
| July 10, 2026 | 360.44M |
| July 09, 2026 | 361.61M |
| July 08, 2026 | 340.68M |
| July 07, 2026 | 351.14M |
| July 06, 2026 | 347.65M |
| July 02, 2026 | 339.52M |
| July 01, 2026 | 351.14M |
| June 30, 2026 | 313.94M |
| June 29, 2026 | 281.38M |
| June 26, 2026 | 244.17M |
| June 25, 2026 | 217.43M |
| June 24, 2026 | 239.52M |
| June 23, 2026 | 251.15M |
| June 22, 2026 | 249.99M |
| June 18, 2026 | 243.01M |
| June 17, 2026 | 227.89M |
| June 16, 2026 | 220.92M |
| June 15, 2026 | 233.71M |
| June 12, 2026 | 239.52M |
| June 11, 2026 | 229.06M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Agenus, Inc. | 326.86M |
| Amgen, Inc. | 239.94B |
| Anika Therapeutics, Inc. | 285.19M |
| BioCryst Pharmaceuticals, Inc. | 2.468B |
| Imunon, Inc. | 7.484M |
Market Cap Related Metrics
| PS Ratio | 44.89 |
| Price to Book Value | 1.852 |
| Price | 2.435 |
| Earnings Yield | -43.24% |